Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

To kick off our three-part immuno-oncology webinar series, Dr. Cawley will highlight recent advancements driven by next-generation sequencing that may lead to a deeper understanding of the cancer ...

Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...

Anderson inks partnership powered by AI cancer diagnostics to develop genomic tools that improve cancer diagnosis and treatment decisions.

CHICAGO, ILLINOIS, UNITED STATES OF AMERICA, June 2, 2024 /EINPresswire.com/ -- Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...